tiprankstipranks
Trending News
More News >
ME Therapeutics Holdings, Inc. (TSE:METX)
:METX
Canadian Market

Compare ME Therapeutics Holdings, Inc. (METX) vs. Competitors

Compare
10 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
ME Therapeutics Holdings, Inc.
C$2.20
C$65.10M
-51.52
-68.57%
Arch Biopartners
C$1.37
C$66.26M
-41.77
-47.34%
Medicenna Therapeutics Corp
C$0.88
C$60.48M
-5.19
-33.33%
1 Buy
0 Hold
0 Sell
Moderate Buy
BriaCell Therapeutics
C$10.64
C$36.52M
-0.09
-92.86%
Defence Therapeutics
C$0.78
C$30.10M
-7.77
-51.33%
Onco-Innovations Ltd.
C$1.47
C$82.58M
-23.04%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TSE:METX
ME Therapeutics Holdings, Inc.
2.20
-5.80
-72.50%
TSE:ARCH
Arch Biopartners
0.99
-0.82
-45.30%
TSE:MDNA
Medicenna Therapeutics Corp
0.88
-0.39
-30.71%
TSE:BCT
BriaCell Therapeutics
5.88
-67.12
-91.95%
TSE:DTC
Defence Therapeutics
0.55
-0.48
-46.60%
TSE:ONCO
Onco-Innovations Ltd.
1.47
-0.60
-28.99%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts